ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,796 | -10.5% | 70 | 0.0% | 0.00% | – |
| Q2 2023 | $2,006 | +19.8% | 70 | 0.0% | 0.00% | – |
| Q1 2023 | $1,675 | +41.2% | 70 | 0.0% | 0.00% | – |
| Q4 2022 | $1,186 | +18.6% | 70 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 70 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 70 | -41.7% | 0.00% | – |
| Q4 2021 | $4,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |